| Financial Year |
March 31 2023 |
| Monetary Funds |
207,217,608.42 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,526,400.00 |
| Accounts Receivable |
830,901,251.49 |
| Advances to Suppliers |
55,962,669.73 |
| Other Receivables |
50,308,534.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
163,459,040.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
127,958,486.23 |
| Other Current Assets |
312,838,627.71 |
| Total Current Assets |
1,763,239,028.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
578,000,654.45 |
| Long-term Equity Investment |
237,005,264.66 |
| Investment Properties |
156,323,425.57 |
| Fixed Assetes |
4,683,817,399.40 |
| Under-construction Projects |
56,161,978.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
271,878,768.69 |
| R&D expenses |
543,244.72 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
550,014,162.96 |
| Deferred Income Tax Assets |
903,968.73 |
| Other Non-Current Assets |
1,179,553.00 |
| Sub-Total of Non-Current Assets |
6,801,331,476.73 |
| Total Assets |
8,564,570,505.49 |
| Short-Term Loans |
157,157,111.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
35,343,259.78 |
| Accounts Payable |
922,997,116.44 |
| Accounts Received In Advance |
623,175.61 |
| Employee Compensation Payable |
144,281,067.75 |
| Taxes Payable |
24,445,535.37 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
160,356,099.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
963,151,856.60 |
| Other Current Liabilities |
13,172,719.64 |
| Sub-Total of Current Liabilities |
3,049,920,151.95 |
| Long-term Loans |
3,111,497,642.23 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
75,160,816.67 |
| Special Payable |
-- |
| Estimatied Liabilities |
255,051.70 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,402,950,429.28 |
| Total Liabilities |
6,452,870,581.23 |
| Paid-In Capital(Or Share Stock) |
1,671,026,239.00 |
| Capital Surplus |
1,086,250,561.54 |
| Surplus Reserve |
236,223,500.88 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-881,485,608.78 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,111,699,924.26 |
| Owner's Equity（Stockholder's Equity） |
2,111,699,924.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,564,570,505.49 |
